{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:38:50Z","timestamp":1790195930379,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/ajg.2009.575","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T11:20:40Z","timestamp":1255432840000},"page":"378-386","source":"Crossref","is-referenced-by-count":29,"title":["NOD2 Mutations and Anti- Saccharomyces cerevisiae Antibodies Are Risk Factors for Crohn's Disease in African Americans"],"prefix":"10.14309","volume":"105","author":[{"given":"Themistocles","family":"Dassopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Vladut","family":"Talor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Wu","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane T","family":"Smoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Oliva-Hemker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore M","family":"Bayless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne C","family":"Burek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/gast.1996.v111.pm8780559","article-title":"Crohns disease: concordance for site and clinical type in affected family members-potential hereditary influences.","volume":"111","author":"Bayless","year":"1996","journal-title":"Gastroenterology"},{"key":"R2-21-20210210","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.1996.v111.pm8780560","article-title":"Crohns disease: influence of age at diagnosis on site and clinical type of disease.","volume":"111","author":"Polito","year":"1996","journal-title":"Gastroenterology"},{"key":"R3-21-20210210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","article-title":"A simple classification of Crohns disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.","volume":"6","author":"Gasche","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"R5-21-20210210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease.","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"R6-21-20210210","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohns disease.","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"R7-21-20210210","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1572-0241.2004.40304.x","article-title":"Differential effects of NOD2 variants on Crohns disease risk and phenotype in diverse populations: a meta-analysis.","volume":"99","author":"Economou","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R8-21-20210210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00054725-200309000-00001","article-title":"Defining complex contributions of NOD2CARD15 gene mutations, age at onset, and tobacco use on Crohns disease phenotypes.","volume":"9","author":"Brant","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"R9-21-20210210","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/gast.2002.32413","article-title":"The molecular classification of the clinical manifestations of Crohns disease.","volume":"122","author":"Ahmad","year":"2002","journal-title":"Gastroenterology"},{"key":"R10-21-20210210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","article-title":"CARD15NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.","volume":"70","author":"Lesage","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R11-21-20210210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1572-0241.2005.40705.x","article-title":"Variants of CARD15 are associated with an aggressive clinical course of Crohns disease-an IG-IBD study.","volume":"100","author":"Annese","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R12-21-20210210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/gast.2002.35393","article-title":"Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohns disease.","volume":"123","author":"Abreu","year":"2002","journal-title":"Gastroenterology"},{"key":"R13-21-20210210","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2002.32415","article-title":"The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.","volume":"122","author":"Cuthbert","year":"2002","journal-title":"Gastroenterology"},{"key":"R14-21-20210210","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","article-title":"Association of NOD2 (CARD 15) genotype with clinical course of Crohns disease: a cohort study.","volume":"359","author":"Hampe","year":"2002","journal-title":"Lancet"},{"key":"R15-21-20210210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/341124","article-title":"CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure.","volume":"71","author":"Vermeire","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R16-21-20210210","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1053\/gast.2002.34020","article-title":"The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohns disease.","volume":"122","author":"Radlmayr","year":"2002","journal-title":"Gastroenterology"},{"key":"R17-21-20210210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.52.4.558","article-title":"CARD15NOD2 gene variants are associated with familially occurring and complicated forms of Crohns disease.","volume":"52","author":"Helio","year":"2003","journal-title":"Gut"},{"key":"R18-21-20210210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ibd.20031","article-title":"Antibodies to Saccharomyces cerevisiae in Crohns disease: higher titers are associated with a greater frequency of mutant NOD2CARD15 alleles and with a higher probability of complicated disease.","volume":"13","author":"Dassopoulos","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R19-21-20210210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R20-21-20210210","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"R21-21-20210210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohns disease into immunologically homogeneous subgroups with distinct clinical characteristics.","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"R22-21-20210210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.","volume":"7","author":"Vermeire","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R23-21-20210210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1590-8658(01)80692-7","article-title":"Detection of anti-Saccharomyces cerevisiae antibodies in Crohns disease: is it a reliable diagnostic and prognostic marker?","volume":"33","author":"Sostegni","year":"2001","journal-title":"Dig Liver Dis"},{"key":"R24-21-20210210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","article-title":"Association of antibody responses to microbial antigens and complications of small bowel Crohns disease.","volume":"126","author":"Mow","year":"2004","journal-title":"Gastroenterology"},{"key":"R25-21-20210210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00054725-200409000-00005","article-title":"Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2CARD15 genotype influence the progression of disease behavior in Crohns disease.","volume":"10","author":"Smith","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R26-21-20210210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2249.2003.02392.x","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohns disease are associated with disease severity but not NOD2CARD15 mutations.","volume":"135","author":"Walker","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R27-21-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ibd.20047","article-title":"The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.","volume":"13","author":"Riis","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R28-21-20210210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gut.2003.030734","article-title":"Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohns disease.","volume":"53","author":"Forcione","year":"2004","journal-title":"Gut"},{"key":"R29-21-20210210","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ibd.20146","article-title":"Seroreactivity to microbial components in Crohns disease is associated with ileal involvement, noninflammatory disease behavior and NOD2CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.","volume":"13","author":"Papp","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R30-21-20210210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.MIB.0000171279.05471.21","article-title":"Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and white children with Crohns disease.","volume":"11","author":"Kugathasan","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R31-21-20210210","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1572-0241.2006.00504.x","article-title":"Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large North American cohort.","volume":"101","author":"Nguyen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R32-21-20210210","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2005.00233.x","article-title":"Impact of race and ethnicity on inflammatory bowel disease.","volume":"100","author":"Basu","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R33-21-20210210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0022-3476(98)70187-8","article-title":"Inflammatory bowel disease in African-American children living in Georgia.","volume":"133","author":"Ogunbi","year":"1998","journal-title":"J Pediatr"},{"key":"R34-21-20210210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MPG.0b013e3180335bb3","article-title":"Disease presentation and clinical course in black and white children with inflammatory bowel disease.","volume":"44","author":"Eidelwein","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R35-21-20210210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MIB.0000217767.98389.20","article-title":"Racial differences in disease phenotypes in patients with Crohns disease.","volume":"12","author":"Cross","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"R36-21-20210210","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00054725-200812001-00026","article-title":"African and European genetic admixture in African American IBD patients.","volume":"14","author":"Wang","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R37-21-20210210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ibd.20144","article-title":"Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC).","volume":"13","author":"Dassopoulos","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R38-21-20210210","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R39-21-20210210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1572-0241.2006.00926.x","article-title":"A population-based case-control study of CARD15 and other risk factors in Crohns disease and ulcerative colitis.","volume":"102","author":"Brant","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R40-21-20210210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/gast.2001.22546","article-title":"Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.","volume":"120","author":"Vermeire","year":"2001","journal-title":"Gastroenterology"},{"key":"R42-21-20210210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.ejhg.5200897","article-title":"Haplotype structure and association to Crohns disease of CARD15 mutations in two ethnically divergent populations.","volume":"11","author":"Croucher","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"R43-21-20210210","first-page":"210","article-title":"NOD2CARD15 gene polymorphisms and susceptibility to Crohns disease in Chinese Han population.","volume":"44","author":"Gao","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R44-21-20210210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mcp.2005.03.001","article-title":"Analysis of the three common mutations in the CARD15 gene (R702W, G908R and 1007fs) in South African colored patients with inflammatory bowel disease.","volume":"19","author":"Zaahl","year":"2005","journal-title":"Mol Cell Probes"},{"key":"R45-21-20210210","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1572-0241.2007.01149.x","article-title":"Prevalence of CARD15NOD2 mutations in Caucasian healthy people.","volume":"102","author":"Hugot","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R46-21-20210210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00251-008-0274-6","article-title":"Evolution of Crohns disease-associated Nod2 mutations.","volume":"60","author":"Gasche","year":"2008","journal-title":"Immunogenetics"},{"key":"R47-21-20210210","doi-asserted-by":"crossref","first-page":"e2769","DOI":"10.1371\/journal.pone.0002769","article-title":"Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.","volume":"3","author":"Meinzer","year":"2008","journal-title":"PLoS ONE"},{"key":"R48-21-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00384-003-0557-1","article-title":"Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohns disease.","volume":"19","author":"Klebl","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"R49-21-20210210","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1572-0241.2004.40486.x","article-title":"A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.","volume":"99","author":"Lawrance","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R50-21-20210210","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/0016-5085(92)90317-R","article-title":"Crohns disease among ethnic groups in a large health maintenance organization.","volume":"102","author":"Kurata","year":"1992","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2009575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009575","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201002000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:20Z","timestamp":1786542380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201002000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2009.575","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}